Browse Antineoplastic agents topic

Product development subtopic

Articles 1-100 out of 100 article(s) Title Author Type Date Words Halozyme Announces Roche Doses First Patient in Phase 3 Clinical Trial with Subcutaneous Herceptin[R]. Oct 22, 2009 907 Phase III, randomized study of gemcitabine and oxaliplatin versus gemcitabine (fixed-dose rate infusion) compared with gemcitabine (30-minute infusion) in patients with pancreatic carcinoma E6201: a trial of the Eastern Cooperative Oncology Group. Guillen, Ponce; Carrato, Alfredo Clinical report Oct 1, 2009 1431 Drug developer tests pancreatic cancer treatment: Abraxis cites progress in treating disease that killed Patrick Swayze. Crowe, Deborah Sep 21, 2009 371 Clinical trial: a company-sponsored clinical study by Amgen Inc. found that its anemia drug Aranesp didn't improve heart conditions of patients with chronic kidney disease, but didn't hurt the patients either. Clinical report Aug 31, 2009 94 New Data from Phase III SATURN Study Showed Tarceva Extended Survival in Patients with Advanced Non-Small Cell Lung Cancer When Used Immediately after Initial Chemotherapy. Clinical report Aug 1, 2009 1436 ACT BIOTECH Announces Treatment of First Gastric Cancer Patients with Telatinib in a Phase 2 Clinical Trial in the U.S. and Spain. Jul 30, 2009 546 Good result: CytRx Corp. Brief article Jul 20, 2009 62 Abraxis BioScience Completes Enrollment of Pivotal Phase III Advanced Lung Cancer Study Evaluating ABRAXANE[R] Vs. Taxol[R]. Clinical report Jul 14, 2009 1711 New Data from Phase III SATURN Study Showed Tarceva Improved Overall Survival When Used Immediately After Initial Chemotherapy in Patients with Advanced Non-Small Cell Lung Cancer. Jul 13, 2009 1202 Intellikine raises $51m in quest for cancer drug. Chambers, Heather Brief article Jul 13, 2009 182 Oral cladribine reduces MS relapses in phase 3 clinical trial. Jun 22, 2009 126 Curis Publishes Preclinical Data for Heat Shock Protein 90 Molecule CUDC-305 in Clinical Cancer Research. Jun 10, 2009 1144 New Data from Satraplatin Phase 3 Trial in Second-Line Castrate-Refractory Prostate Cancer Presented at 2009 ASCO Annual Meeting. Jun 2, 2009 1189 Fate tests experimental drug: treatment would help replenish blood systems. Chambers, Heather Jun 1, 2009 471 Aphios Announces Presentation of Phase II/III Clinical Trial Data on Zindol[R] for Cancer Chemotherapy Induced Nausea. May 26, 2009 487 Data from the Phase III SATURN Study Show Tarceva Improved Progression-Free Survival When Used as a First-Line Maintenance Therapy for Advanced Non-Small Cell Lung Cancer. May 15, 2009 2115 Endocyte Initiates Phase 1 Trial of EC0489 for Treatment of Refractory or Metastatic Solid Tumors. May 6, 2009 551 Cancer biomarkers--a good start. Little, Stephen Cover story May 1, 2009 1550 mTOR as a validated cancer target. Brief article May 1, 2009 191 Isis offers hope. Brief article May 1, 2009 210 Seattle Genetics Presents Preclinical Data on Antibody-Drug Conjugate Programs at AACR. Apr 22, 2009 828 Biotech seeking to disrupt how bacteria communicate. Chambers, Heather Apr 13, 2009 626 Traversa picks up series B funding. Allen, Mike Brief article Apr 13, 2009 93 LEUCHEMIX PROVIDES UPDATE ON CANCER TRIAL. Mar 1, 2009 498 Journal Review: Phase 1 oncology trial patients don't ask for palliative care. Mar 1, 2009 231 Multiple Myeloma Research Consortium (MMRC) and Merck Initiate Phase II Trial of Zolinza with Velcade in Relapsed and Refractory Multiple Myeloma Patients. Jan 16, 2009 803 Burzynski Research Institute Gets SPA Clearance from the FDA to Initiate Pivotal Phase III Trial of Combination Antineoplaston Therapy and Radiation Therapy. Jan 13, 2009 663 United States: MSHL FDA Approval to Begin Phase Ib Trial of Triphendiol. Jan 9, 2009 143 Major investment for Karus. Brief article Jan 1, 2009 252 ARIAD Presents Preclinical Data on Its Kinase Inhibitor, AP24534, Demonstrating Inhibition of All Known Variants of the CML Target Protein Bcr-Abl. Dec 9, 2008 1110 Study suspended: Amgen Inc. and Japanese partner Takeda Pharmaceutical Co. said they have suspended a clinical trial of their experimental cancer drug motesanib after seeing a trend of higher deaths among lung cancer patients getting the drag, compared with those receiving a placebo. Nov 24, 2008 98 Germany: Lpath and Merck Serono form alliance for cancer drug development. Nov 3, 2008 291 CYTOPIA BEGINS SECOND PHASE II STUDY IN BRAIN CANCER. Oct 1, 2008 686 Affymetrix and Medical Prognosis Institute Collaborate to Develop Cancer Treatment Products. Oct 1, 2008 1019 Cook Medical Completes Enrollment in First International Trial of First-of-Its-Kind Drug-Eluting Peripheral Stent. Sep 10, 2008 884 Progenics Initiates Phase 1 Clinical Study of Targeted Therapy for Prostate Cancer. Sep 8, 2008 1689 Clinical Trial Protocol Against Cancer Therapy Side Effects (Mucositis) Approved. Sep 3, 2008 335 OncoVista Innovative Therapies to Begin Enrolling Patients in a Phase I/II Study of Cordycepin in Patients with Refractory TdT-Positive Leukemia. Jul 22, 2008 437 The Multiple Myeloma Research Consortium (MMRC) Announces the Initiation of Phase I/II Study of Elotuzumab (Huluc63) Monoclonal Antibody in Combination with Velcade. Report Jul 18, 2008 677 Germany: Merck KGaA starts Phase III study of Erbitux on gastric cancer. Jul 11, 2008 230 IMC-A12 Plus Temsirolimus Clinical Trial for Advanced Cancer Opens for Patient Enrollment. Jun 25, 2008 1173 CB1400, Patented by Canopus BioPharma, Enters Phase II Clinical Trials for the Prevention of Mucositis in Patients with Cancer of the Head and Neck. Jun 23, 2008 391 Drug trials positive for Seattle Genetics; New cancer treatment; Talks with FDA to speed approval. Jun 4, 2008 405 New Data from Several Satraplatin Clinical Trials in Solid Tumors Presented at 44th ASCO Annual Meeting. Jun 2, 2008 1659 Data from Satraplatin SPARC Phase 3 Trial in Patients with Hormone-Refractory Prostate Cancer Progressing after Initial Chemotherapy Presented at 44th ASCO Annual Meeting. Jun 2, 2008 1251 Seattle Genetics Announces Initiation of SGN-40 Phase Ib Clinical Trial in Combination With Velcade for Multiple Myeloma. Jun 2, 2008 829 Updated Data from Ongoing Phase 3 Trials Support the Continued Study of Vectibix(R) (panitumumab) in Combination with Standard Chemotherapy. Jun 1, 2008 2206 ERBITUX(R) (Cetuximab) Data Demonstrate Improved Overall Survival in First-Line Treatment of Advanced Non-Small Cell Lung Cancer. Clinical report May 31, 2008 2583 Vall d'Hebron University Hospital and Cyclacel to Initiate Phase 1 Combination Study of Seliciclib and Tarceva(R) in Advanced Cancers. May 29, 2008 1094 GPC Biotech Announces Data from Several Satraplatin Clinical Trials to be Presented at ASCO Annual Meeting. May 28, 2008 499 Array BioPharma and AstraZeneca Announce New Phase 2 Development Plans for the Investigational Anti-Cancer Drug AZD6244 (ARRY-886). May 16, 2008 691 United States: Phase II study of IMC-A12 for advanced Liver Cancer opens for Patient Enrollment. Report May 15, 2008 213 Cellceutix Obtains Initial Funding to Advance Its Head and Neck Cancer Drug. May 14, 2008 266 Phase II Study of IMC-A12 for Advanced Liver Cancer Opens for Patient Enrollment. Report May 13, 2008 1018 Sirtex Receives FDA Approval for FAST Clinical Trial. Apr 15, 2008 641 Significant Tumor-Specific Immune Response Observed in AVANT's Phase 2 Trial Evaluating CDX-110 with Temozolomide for Treatment of Glioblastoma Multiforme. Apr 15, 2008 1504 Seattle Genetics Announces Initiation of Phase Ib Clinical Trial of SGN-40 in Combination with Rituxan and Gemzar for Non-Hodgkin Lymphoma. Apr 8, 2008 785 Seattle Genetics Initiates SGN-33 Clinical Trial in Combination with Revlimid(R) for Myelodysplastic Syndromes (MDS). Mar 20, 2008 882 Phase I/II Studies of IMC-A12 in Pediatric Cancer Patients Commence Enrollment. Mar 5, 2008 1019 Phase II Study of IMC-1121B for Advanced Liver Cancer Commences Patient Enrollment. Feb 22, 2008 789 Weighty evidence: the link between obesity, metabolic hormones, and tumors brings the promise of new targets for cancer therapies. Beil, Laura Feb 16, 2008 1953 Geron Ranked in Biotechnology Patent Scorecard Published in The Wall Street Journal. Feb 14, 2008 470 Spectrum Pharmaceuticals Initiates Phase 1 Study of SPI-1620, a Novel Adjunct to Cancer Chemotherapy. Feb 8, 2008 754 ApoCell to Conduct Studies in Support of Novel Pfizer Cancer Drug Trial. Jan 24, 2008 330 Xanthus Announces Oral Fludarabine NDA Accepted for Review by U.S. FDA. Jan 22, 2008 629 Seattle Genetics Earns Milestone Payment from Initiation of SGN-40 Phase Ib Clinical Trial in Combination with Rituxan for Non-Hodgkin Lymphoma. Jan 7, 2008 746 The Angeles Clinic and Research Institute Initiates Global Phase 3 Clinical Trial for New Melanoma Drug. Jan 7, 2008 759 FDA Approves Phase I Clinical Trial for SKCC Breast Cancer Vaccine. Dec 10, 2007 530 Seattle Genetics Initiates SGN-40 Phase IIb Clinical Trial in Combination with Rituxan and Chemotherapy for Diffuse Large B-Cell Non-Hodgkin's Lymphoma. Dec 7, 2007 771 No new patients for Merck, Vertex trials. Brief article Dec 3, 2007 145 Synta Reaches Agreement on Special Protocol Assessment and Initiates SYMMETRY Trial - a Pivotal Phase 3 Clinical Trial of Elesclomol in Metastatic Melanoma. Nov 12, 2007 1913 Therapy trial encouraging; Seattle Genetics; 75% of enrolled patients saw tumors shrink, firm says. Nov 6, 2007 405 Life extension-funded cancer research. Faloon, William Nov 1, 2007 2470 Apthera Announces Completion of End of Phase II Meeting with the U.S. Food and Drug Administration for NeuVax(TM) for Breast Cancer. Oct 31, 2007 303 Biovest Announces Strategy for Seeking Early Approval of Its Anti-Cancer Vaccine for Non-Hodgkins Lymphoma. Oct 16, 2007 1212 First Patient Registered in Investigator-Sponsored Phase 2 Trial of Antigenics' Oncophage Cancer Vaccine in Glioma. Oct 10, 2007 853 Biothera Initiates Phase Ib/IIa Clinical Trial with Imprime PGG and Erbitux in Metastatic Colorectal Cancer Patients. Oct 9, 2007 336 First Patient Enrolled in Phase II Cancer Trial. Oct 3, 2007 573 Novel cancer drug shows promise. Kiefer, Dale Brief article Oct 1, 2007 160 ImClone Systems Expands IMC-A12 Development with Ten New Planned Clinical Trials. Sep 20, 2007 689 Advanced Viral Research Corp. to Initiate Phase II Trial in Cancer Patients. Sep 5, 2007 536 OncoGenex Technologies. Brief article Sep 1, 2007 132 Phase 0 trials speed early drug development. McBride, Deborah Sep 1, 2007 630 Phase II Study of IMC-A12 for Advanced Prostate Cancer Commences Patient Enrollment. Aug 29, 2007 546 Hana Biosciences Initiates Marqibo(R) Phase 2 Clinical Trial in Relapsed Acute Lymphoblastic Leukemia (All). Aug 3, 2007 1170 A randomized, placebo-controlled, double-blind clinical trial of curcuminoids in oral lichen planus. Chainani-Wu, N.; Silverman, S., Jr.; Reingold, A.; Bostrom, A.; Mc Culloch, C.; Lozada-Nur, F.; Wein Report Aug 1, 2007 6054 S*BIO INITIATES CLINICAL TRIAL OF NOVEL ANTI-CANCER DRUG. Aug 1, 2007 473 Enzon Commences Enrollment of Two Phase 1 Studies of PEG-SN38 for Advanced Solid Tumors and Lymphoma. Aug 1, 2007 697 There Are Currently More Than 400 Antibody Based Drugs in Development for the Treatment of Cancer. Jun 15, 2007 318 Geron's Telomerase Inhibitor Cancer Drug Demonstrates Good Pharmacokinetics and Tolerability in Phase I/II Trial. Jun 12, 2007 912 Phase III Clinical Trial with 4-Month Long-Acting Formulation of Triptorelin: Ipsen Decides Not to Perform Further Administration. Jun 11, 2007 792 ZIO-301 (Indibulin) Interim Phase I Data Presented at ASCO. Jun 3, 2007 675 Angiogenesis and breast cancer. Gillmore, Roopinder; Miles, David Jun 1, 2007 2456 2007 American Society of Clinical Oncology (ASCO) annual meeting. Barrett-Lee, Peter Conference notes Jun 1, 2007 1059 SRI International Reacquires Rights to Tirapazamine, a Phase III Cancer Drug. May 7, 2007 441 Abraxis BioScience to Initiate Two Phase I/II Clinical Trials with nab-docetaxel in Hormone Refractory Prostate and Metastatic Breast Cancer. Mar 20, 2007 1375 Cancer drug shows promise in early trial. Bateman, Chris Brief article Mar 1, 2007 141 Cytogen Announces Initiation of Phase 1 Trial for Radiolabeled Antibody for the Treatment of Hormone-Refractory Prostate Cancer. Feb 27, 2007 932 Bacteria-based immune therapy targets liver metastases. Brief article Jan 1, 2007 255 IND for MDX-1401. Brief article Jan 1, 2007 170